Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. - Wikidata - awgldk - TriplyDB

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

http://www.wikidata.org/entity/Q34132798

about

Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies Recent advances in pathogenesis, assessment, and treatment of atherosclerosis PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque.Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques Vessel Wall Imaging of the Intracranial and Cervical Carotid Arteries Positron emission tomography imaging of atherosclerosis Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque Non-invasive imaging of atherosclerosis Imaging and nanomedicine in inflammatory atherosclerosis Monocytes as regulators of inflammation and HIV-related comorbidities during cART Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease Non-invasive vulnerable plaque imaging: how do we know that treatment works?The development, past achievements, and future directions of brain PET Periaortic brown adipose tissue as a major determinant of [¹⁸F]-fluorodeoxyglucose vascular uptake in atherosclerosis-prone, apoE-/- mice Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets.Unstable carotid artery plaque: new insights and controversies in diagnostics and treatment.Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications.Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies.Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study NIH workshop on clinical translation of molecular imaging probes and technology--meeting report.Imaging atherosclerosis and vulnerable plaque.Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.Multimodality cardiovascular molecular imaging, Part II Molecular imaging of inflammation in atherosclerosis.Emerging diagnostic and therapeutic molecular imaging applications in vascular disease PET/MRI: current state of the art and future potential for cardiovascular applications.Progress in atherosclerotic plaque imaging.Cardiovascular molecular imaging: focus on clinical translation Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.High-resolution [18]fluorodeoxyglucose-positron emission tomography and coregistered magnetic resonance imaging of atherosclerotic plaque from a patient undergoing carotid endarterectomy.Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance.Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images.18F-Fluoride and 18F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke: Case-Control Study.In vivo detection of macrophages in a rabbit atherosclerotic model by time-resolved laser-induced fluorescence spectroscopy.Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation.

P2860

Q26738576-4C81833D-110E-4E75-B151-5C98AAB3CE1C Q26738588-6475FADF-A848-40BF-AAA4-2797094213CB Q26740304-7BE7B754-E08B-4362-99F0-6A93FB48EF32 Q26750798-EDE42D44-CE22-4E97-96AB-36CA2EBFF890 Q26769824-C44F6EA9-3604-4215-8930-93F7C9C2FE26 Q26781838-2A00A175-9395-4AF1-9422-F36A036BC92E Q26781925-7A7CF307-290C-4109-A3BE-2B43B33525E7 Q26824610-7622DFA9-2054-4768-8361-F714D9599BF5 Q26824883-760FA941-46DA-44DD-8F0D-126D5E93C456 Q26992143-05CB85A6-ECC0-447F-87AD-1E79A16C4C97 Q27002916-CB685FB2-F95C-43ED-9B67-ADC52BCD0046 Q27006827-FC844CAA-71F4-4705-985A-88B6EE4F460E Q27011260-3ED4F0F8-05E8-4CD8-8F8D-28AEE008777E Q27011866-4BE5DA61-337D-4296-89C5-3F3F3ECB4CF4 Q27020959-6C826184-A3AA-4388-926A-A91CD2D95E2D Q27026331-45A763F4-51C8-4473-881C-A2C4E50CA602 Q27324089-DB2D6C3F-10B7-42E5-9C99-73AEEEBD307A Q27692593-18E5ECD0-177D-4E53-9FC2-FAA02652B52D Q28066956-107D4E78-DBB6-448E-B4F1-A1E3D00B4DA3 Q30249617-574AF12D-2AD8-4D20-BECE-C9080A6B742E Q30364399-18507A15-3D07-4BD1-9B3C-5D06A495E0A9 Q30401532-94F18933-0643-4815-915E-57C320B8D829 Q30414631-C55F7A57-E1B2-45D6-A642-D05E5FA18556 Q30430958-0EB89BB2-3C8C-44C2-B93A-E4877B18BE50 Q30435383-58B1593A-FE29-415C-82C5-99A93DEAB2B2 Q30436195-1EF77401-8F46-4671-BF15-62643C845197 Q30438207-6CAE5253-54CE-4C30-A4FB-E6A12EADDFBB Q30446268-80FA5E48-E0F7-4BC8-BE44-9E5C05D4FB70 Q30450437-64DB962E-FC30-4D8F-A247-F86219D5C5A0 Q30456937-0F8D3B53-0C5F-40D8-B442-627598E21AF3 Q30464390-D89664D3-4FB5-403A-8B1C-E0FB3EB60A9A Q30470859-81455FD9-8208-4CE4-9D37-E5C999F89DFB Q30479243-1CD7C53A-1CAD-457C-8BCD-C2361C420193 Q30484224-244A200A-2813-456D-9B59-0E60434DAC44 Q30532182-1610D3F6-78A5-49BA-BAA5-3006AD138F9A Q30533932-C5DBAD00-48FC-4025-A41D-B9E8901034D3 Q30744971-5DE39BFC-670E-458E-BD09-949FF5402A53 Q30842993-77744B4F-4B07-4B08-9CF9-6BDDAD83CB3C Q33220185-936809BC-E3AF-4A12-847E-7BFFCA53A0D4 Q33244720-325FD84C-09EB-4B4B-B8E0-A14B4F226405

P2860

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

http://www.wikidata.org/entity/Q34132798

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Imaging atherosclerotic plaque ...... positron emission tomography.

@ast

Imaging atherosclerotic plaque ...... positron emission tomography.

@en

Imaging atherosclerotic plaque ...... positron emission tomography.

@nl

type

label

Imaging atherosclerotic plaque ...... positron emission tomography.

@ast

Imaging atherosclerotic plaque ...... positron emission tomography.

@en

Imaging atherosclerotic plaque ...... positron emission tomography.

@nl

prefLabel

Imaging atherosclerotic plaque ...... positron emission tomography.

@ast

Imaging atherosclerotic plaque ...... positron emission tomography.

@en

Imaging atherosclerotic plaque ...... positron emission tomography.

@nl

P1433

Q34132798-DC12D727-7197-411C-9488-02A0A17E3580

P1476

Q34132798-B3C49045-020B-4FEE-ADCF-37D019C17A56

P2093

Q34132798-01DB7293-68C2-4ED1-827D-0441497A68EA

Q34132798-272C5056-31E1-4542-8718-482E65386D62

Q34132798-45F70CE8-9539-491D-9668-079447B1ECD9

Q34132798-6F13B30C-8972-4D03-9D89-472DB68F22B0

Q34132798-72F90264-AB24-4CDD-A467-3256ABEA1A82

Q34132798-8B394A0E-9BC0-4C20-9FF6-E3713211442B

Q34132798-9BDE95BB-6B3A-4377-9F23-F3F9BB3CB9AA

Q34132798-E1131713-3F34-4F9B-A198-3C376B0E01F0

Q34132798-E99D1D7C-138C-41D3-BDD0-9DEA39A6F850

Q34132798-ED4D9B5B-2DF9-4DB3-AF17-C1728B8D238A

P304

Q34132798-85BBB10E-0B37-41C0-98E8-FA5250E65E0C

P31

Q34132798-766C5C70-D883-422A-876C-E30742E6D50C

P356

Q34132798-5A72E323-C395-4005-A8C2-876A4765A9B4

P407

Q34132798-D9914F98-BB51-4405-AB30-08A3AD4AB652

P433

Q34132798-2FF039E8-BAE4-4C1D-A1B0-E93795FDDDAD

P478

Q34132798-27B87303-E477-4112-8822-4DB4E06998AD

P50

Q34132798-405CD95E-D90D-46E7-A53B-0799D6CD9D52

P577

Q34132798-6AFFB2D1-61C4-45A1-B207-7683A00772D4

P698

Q34132798-A90C4C5E-7F79-40A4-B22A-9143526C5EB4

P921

Q34132798-531F917C-90DD-4E82-8805-B1B829B095BB

Q34132798-E151C1EE-9208-472F-ACAC-8385A87B1F08

P356

01.CIR.0000020548.60110.76

P1433

P1476

Imaging atherosclerotic plaque ...... e positron emission tomography

@en

P2093

B N Arch

http://www.w3.org/2001/XMLSchema#string

E A Warburton

http://www.w3.org/2001/XMLSchema#string

H A Jones

http://www.w3.org/2001/XMLSchema#string

J C Clark

http://www.w3.org/2001/XMLSchema#string

J D Pickard

http://www.w3.org/2001/XMLSchema#string

J H F Rudd

http://www.w3.org/2001/XMLSchema#string

N Antoun

http://www.w3.org/2001/XMLSchema#string

P J Kirkpatrick

http://www.w3.org/2001/XMLSchema#string

P Johnström

http://www.w3.org/2001/XMLSchema#string

P L Weissberg

http://www.w3.org/2001/XMLSchema#string

P304

2708-2711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000020548.60110.76

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Anthony P Davenport

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12057982

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis